Companies: 49,247 Total Market Cap: 132839059355412.03

Rebus Holdings

OTC-RBSH

Healthcare Biotechnology

Rank #48994

Market Cap 3,213

Volume 404

Price 0

Change (%) 0.00%

Country or region

United States

Rebus Holdings's latest marketcap:

3,213

As of 05/21/2025, Rebus Holdings's market capitalization has reached $3,213. According to our data, Rebus Holdings is the 48994th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap	3,213
Revenue (ttm)	0
Net Income (ttm)	570,000
Shares Out	32.13 M
EPS (ttm)	0.02
Forward PE	0.00
Ex-Dividend Date	n/a
Earnings Date	n/a

Market Cap Chart

Data Updated: 05/21/2025

Rebus Holdings's yearly market capitalization.

Rebus Holdings has seen its market value drop from $911,250 to $3,213 since 2020, representing a total decrease of 99.65% and an annual compound decline rate (CAGR) of 72.40%.

Date	Market Cap	Change (%)
05/21/2025	$3,213	9940.62%
12/31/2024	$32	-99.98%
12/29/2023	$162,271	-32.67%
12/30/2022	$240,997	-12.12%
12/31/2021	$274,225	-69.91%
12/31/2020	$911,250

Company Profile

About Rebus Holdings, Inc.

Rebus Holdings, Inc., together with its subsidiaries, is a biotechnology company dedicated to advancing precision therapeutics for cancer treatment.

Key Focus Areas

Lead Asset: RT-AR001, an adenosine receptor antagonist designed to enhance tumor infiltration and improve treatment outcomes when administered intra-tumorally.
Research & Development: Specializes in innovative therapies targeting cancer with a focus on precision medicine.

Company Overview

Founded in 2003, Rebus Holdings, Inc. is headquartered in Westlake Village, California, and continues to drive advancements in oncology therapeutics.

Frequently Asked Questions

As of 05/21/2025, Rebus Holdings (including the parent company, if applicable) has an estimated market capitalization of $3,213 USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Rebus Holdings global market capitalization ranking is approximately 48994 as of 05/21/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region	United States
Founded	2003
IPO Date	n/a
Employees	1
CEO	Raul Silvestre
Sector	Healthcare
Industry	Biotechnology
Address	2629 Townsgate Road Westlake Village, Delaware 91361 United States
Website	https://www.rebus-corp.com